Insider Sale: See Remarks of $CORT (CORT) Sells 5,000 Shares

Quiver QuantitativeJan 6 19:32 ET

Here's Why Corcept Therapeutics (NASDAQ:CORT) Has Caught The Eye Of Investors

Simply Wall StJan 1 13:39 ET

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT NewswiresDec 31, 2024 08:58 ET

Corcept Therapeutics Submits New Drug Application for Cushing's Sydrome Treatment

WSJDec 30, 2024 17:48 ET

Corcept Therapeutics Submits New Drug Application To FDA For Its Proprietary, Selective Cortisol Modulator, Relacorilant, To Treat Patients With Cushing's Syndrome

BenzingaDec 30, 2024 17:16 ET

Express News | Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism

ReutersDec 30, 2024 17:15 ET